SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$15.42
Tradestie Score
49
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+85.5%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$274.50
|
$12.36B | 31.3 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$55.85
|
$11.09B | 17.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.13
|
$10.76B | - | 59 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$79.76
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.99
|
$10.53B | 41.6 | 63 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$81.80
|
$10.49B | - | 64 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$77.19
|
$10.22B | - | 62 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$528.10
|
$10.01B | - | 59 | Compare |
|
TECH
Bio-Techne Corp.
|
$70.83
|
$9.33B | 101.4 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$90.21
|
$8.88B | 248.4 | 58 | Compare |
More SMMT Analysis
Data updated: Jul 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry